The IOF Global Patient Charter, an initiative of the International Osteoporosis Foundation (IOF) which was drafted in cooperation with patient societies worldwide in 2017, seeks to drive global action for fracture prevention and improved patient care.  Read more
After a fracture, and without appropriate treatment for osteoporosis (the underlying disease) a fracture patient is at high risk for breaking more bones, especially over the next 1 to 2 years. Despite the danger, a vast majority of patients remain untreated, and are essentially unprotected against the high risk of life-threatening secondary fractures. Read more
The International Osteoporosis Foundation (IOF), the European Society for Clinical and Economic Aspects Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Association of Geriatrics and Gerontology (IAGG) have agreed to work in partnership with regard to collaboration on research, education, trai Read more
Del 14 al 23 de octubre de 2019 el Dr. Philippe Halbout, CEO de la IOF, visitó nuestra operación regional con el objetivo de tomar contacto directo con las iniciativas IOF en América Latina y sus protagonistas junto a la Lic. Mónica Caló, regional manager, LATAM. El Dr. Read more
Asian countries are seeing an immense increase in their aged populations and consequent rise in fractures. The impending fragility fracture crisis is so dire that health authorities are now acknowledging the urgent need to make fracture prevention a top healthcare priority. Read more
In seniors, hip fractures and resulting immobility result in high morbidity, and mortality of up to 30% in the first year. As yet, there is no therapy available to address the problem of impaired regeneration and mobility, and the consequences (including high mortality) after hip fracture surgery. Hipgen is a multicenter phase III trial which aims to bring allogenic placental cell therapy with... Read more
On May 4, 2019, the Asia Pacific Consortium on Osteoporosis (APCO) was launched at a meeting in Singapore. The meeting was attended by 24 clinical experts from across the Asia Pacific region. The consortium aims to develop solutions to pressing challenges facing osteoporosis management and fracture prevention in this highly populous part of the world. Read more
It is with great sadness that IOF learned of the sudden death of Professor Howard Morris, President of the International Federation of Clinical Chemistry (IFCC), who passed away on April 18, 2019, while in Kazakhstan where he was lecturing as an IFCC Visiting Lecturer. Read more
The Committee of National Societies (CNS) Day, held exclusively for IOF member societies, encompassed a full day’s programme of engaging and informative sessions that focused on topics of relevance to national patient societies worldwide. Following the successful event, IOF CEO’s stated: Read more
Los testimonios de pacientes son la forma más poderosa de mostrar el enorme impacto que las fracturas por osteoporosis tienen en la vida diaria. Con el objetivo de amplificar la voz del paciente y mostrar la universalidad de la osteoporosis, la IOF lanzó a fines del año pasado el concurso de videos 'Give Patients a Voice' en cooperación con sus sociedades miembro de todo el mundo. Read more


Subscribe to IOF